| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |